top of page
Antibody-Drug Conjugate
NEXJENNER SERVICE
Turn key style
Antibody-Drug Conjugate (ADC)
Development & Manufactureing
ADCs, biosynthetic fusion drugs combining antibodies and drugs via a suitable linker
are being developed as novel drugs with highly targeted therapeutic effects
and significantly reduced cytotoxic side effects.
ADC Design and Development Support Services
Antibody selection
Target (bio)marker proposal
Design and fabrication of disease-specific linkers
Design and fabrication of disease-specific linkers
Drug selection
Proposal and selection of effective therapeutics including anticancer and autoimmune disease treatments
BGMP Sample Production
Small-scale production of drugs for nonclinical and clinical trials
ADC Analysis Services
Toxicity Review / Validation
Single and Repeated Dosage, Non-Target Toxicity, Immunogenicity
Chemical Analysis
DAR, Residual solvent, Free drug
Assay Validation
FPLC, LC/MS, ELISA
In vitro/in vivo Testing
Cytotoxicity Testing, Laboratory Animal Disease
Specificity Confirmation
bottom of page